{"id":33395,"date":"2025-01-24T14:00:00","date_gmt":"2025-01-24T14:00:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/4602881_CN02881_0"},"modified":"2025-01-24T14:00:00","modified_gmt":"2025-01-24T14:00:00","slug":"nuevocor-welcomes-andreas-wallnofer-as-chairman-of-the-board-of-directors","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=33395","title":{"rendered":"Nuevocor Welcomes Andreas Walln\u00f6fer as Chairman of the Board of Directors"},"content":{"rendered":"<table name=\"logo_release\" border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2382409\/Nuevocor_Logo.jpg?p=medium600\" border=\"0\" alt title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span class=\"legendSpanClass\"><span class=\"xn-location\">SINGAPORE<\/span> and <span class=\"xn-location\">PHILADELPHIA<\/span><\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Jan. 24, 2025<\/span><\/span> \/PRNewswire\/ &#8212; <a href=\"https:\/\/www.nuevocor.com\/\" target=\"_blank\" rel=\"nofollow noopener\">Nuevocor<\/a>, an IND-stage biotechnology company dedicated to developing functional cures to treat cardiomyopathies with aberrant mechanobiology, today announces the appointment of <b>Dr. Andreas Walln\u00f6fer<\/b> as Chairman of Nuevocor&#8217;s Board of Directors. &nbsp;&nbsp;<\/p>\n<p>Andreas Walln\u00f6fer has over 25 years of experience in the pharmaceutical and biotech industry, including 12 years&nbsp;as a member of the F. Hoffmann-La Roche Pharma R&amp;D Executive Leadership team and nearly a decade serving as a board member for several biotechnology companies. He has been a Partner at the Swiss venture capital firm BioMedPartners and later at Jeito Capital, a global leading European investment company based in <span class=\"xn-location\">Paris<\/span>.<\/p>\n<p>An accomplished investor, board member and operator, Andreas has played a pivotal role in successfully developing many innovative companies. He has contributed to numerous successful exits, including the recent acquisition of EyeBio by MSD for a total deal value of <span class=\"xn-money\">US$3 billion<\/span>, achieved only three years after the company&#8217;s inception.<\/p>\n<p>Prior to his career in venture capital, he was Head of Cardiovascular and Metabolism (CVM) R&amp;D at Roche and a member of the Roche\/Genentech Portfolio Committee. Andreas was part of several successful product developments and market introductions. Before the integration of Genentech (now a wholly owned member of the Roche Group), Andreas was Global Head of Clinical Research and Exploratory Development and led the R&amp;D organization at multiple sites in <span class=\"xn-location\">Europe<\/span>, the U.S., and <span class=\"xn-location\">Asia<\/span>. He had a key role in the integration of the Roche and Genentech development organizations and, subsequently, led Roche&#8217;s Early Development Department.<\/p>\n<p>&#8220;We are extremely pleased to welcome Andreas as Chairman of Nuevocor&#8217;s Board and look forward to benefiting from his experience in life-sciences investment as well as expertise in cardiovascular diseases,&#8221; said <b>Dr. <span class=\"xn-person\">Yann Chong Tan<\/span>, PhD, CEO and Co-Founder of Nuevocor<\/b>. &#8220;Having moved several companies towards successful exits, Andreas&#8217; experience will be a major asset to Nuevocor as we continue to grow and demonstrate the value of our therapeutic assets in treating cardiomyopathies.&#8221;<\/p>\n<p>&#8220;Nuevocor is at the frontier of next generation gene therapy. Particularly as former Head of Cardiovascular Research and Development at Roche, it is very motivating to see how Nuevocor&#8217;s promising technology may sustainably benefit and improve the lives of patients with cardiomyopathies&#8221;&nbsp;said <b>Dr. Andreas Walln\u00f6fer<\/b>.<\/p>\n<p><b>About Nuevocor<\/b><\/p>\n<p>Nuevocor is a biotechnology company that is pioneering an innovative pathway-centric approach to developing functional cures for heart conditions known as cardiomyopathies. By harnessing our PrOSIA<b>\u2122<\/b>&nbsp;mechanobiology platform, Nuevocor designs genetic medicines to target the biomechanical root cause of these diseases. Nuevocor&#8217;s approach surpasses the limitations of traditional gene therapy, which focuses on individual gene mutations, to treat defects within shared disease pathways across multiple genetic cardiomyopathies. This enables us to extend our impact to broader patient populations.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>SINGAPORE and PHILADELPHIA, Jan. 24, 2025 \/PRNewswire\/ &#8212; Nuevocor, an IND-stage biotechnology company dedicated to developing functional cures to treat cardiomyopathies with aberrant mechanobiology, today announces the appointment of Dr. Andreas Walln\u00f6fer as Chairman of Nuevocor&#8217;s Board of Directors. &nbsp;&nbsp; Andreas Walln\u00f6fer has over 25 years of experience in the pharmaceutical and biotech industry, including [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-33395","post","type-post","status-publish","format-standard","hentry","category-business-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nuevocor Welcomes Andreas Walln\u00f6fer as Chairman of the Board of Directors - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=33395\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nuevocor Welcomes Andreas Walln\u00f6fer as Chairman of the Board of Directors - My Blog\" \/>\n<meta property=\"og:description\" content=\"SINGAPORE and PHILADELPHIA, Jan. 24, 2025 \/PRNewswire\/ &#8212; Nuevocor, an IND-stage biotechnology company dedicated to developing functional cures to treat cardiomyopathies with aberrant mechanobiology, today announces the appointment of Dr. Andreas Walln\u00f6fer as Chairman of Nuevocor&#8217;s Board of Directors. &nbsp;&nbsp; Andreas Walln\u00f6fer has over 25 years of experience in the pharmaceutical and biotech industry, including [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=33395\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-24T14:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnasia.com\/media2\/2382409\/Nuevocor_Logo.jpg?p=medium600\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=33395#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=33395\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"Nuevocor Welcomes Andreas Walln\u00f6fer as Chairman of the Board of Directors\",\"datePublished\":\"2025-01-24T14:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=33395\"},\"wordCount\":478,\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=33395#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2382409\\\/Nuevocor_Logo.jpg?p=medium600\",\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=33395\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=33395\",\"name\":\"Nuevocor Welcomes Andreas Walln\u00f6fer as Chairman of the Board of Directors - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=33395#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=33395#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2382409\\\/Nuevocor_Logo.jpg?p=medium600\",\"datePublished\":\"2025-01-24T14:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=33395#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=33395\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=33395#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2382409\\\/Nuevocor_Logo.jpg?p=medium600\",\"contentUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2382409\\\/Nuevocor_Logo.jpg?p=medium600\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=33395#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nuevocor Welcomes Andreas Walln\u00f6fer as Chairman of the Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nuevocor Welcomes Andreas Walln\u00f6fer as Chairman of the Board of Directors - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=33395","og_locale":"en_US","og_type":"article","og_title":"Nuevocor Welcomes Andreas Walln\u00f6fer as Chairman of the Board of Directors - My Blog","og_description":"SINGAPORE and PHILADELPHIA, Jan. 24, 2025 \/PRNewswire\/ &#8212; Nuevocor, an IND-stage biotechnology company dedicated to developing functional cures to treat cardiomyopathies with aberrant mechanobiology, today announces the appointment of Dr. Andreas Walln\u00f6fer as Chairman of Nuevocor&#8217;s Board of Directors. &nbsp;&nbsp; Andreas Walln\u00f6fer has over 25 years of experience in the pharmaceutical and biotech industry, including [&hellip;]","og_url":"https:\/\/transmediavictoria.net.au\/?p=33395","og_site_name":"My Blog","article_published_time":"2025-01-24T14:00:00+00:00","og_image":[{"url":"https:\/\/mma.prnasia.com\/media2\/2382409\/Nuevocor_Logo.jpg?p=medium600","type":"","width":"","height":""}],"author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=33395#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=33395"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"Nuevocor Welcomes Andreas Walln\u00f6fer as Chairman of the Board of Directors","datePublished":"2025-01-24T14:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=33395"},"wordCount":478,"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=33395#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnasia.com\/media2\/2382409\/Nuevocor_Logo.jpg?p=medium600","articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=33395","url":"https:\/\/transmediavictoria.net.au\/?p=33395","name":"Nuevocor Welcomes Andreas Walln\u00f6fer as Chairman of the Board of Directors - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=33395#primaryimage"},"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=33395#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnasia.com\/media2\/2382409\/Nuevocor_Logo.jpg?p=medium600","datePublished":"2025-01-24T14:00:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=33395#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=33395"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transmediavictoria.net.au\/?p=33395#primaryimage","url":"https:\/\/mma.prnasia.com\/media2\/2382409\/Nuevocor_Logo.jpg?p=medium600","contentUrl":"https:\/\/mma.prnasia.com\/media2\/2382409\/Nuevocor_Logo.jpg?p=medium600"},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=33395#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"Nuevocor Welcomes Andreas Walln\u00f6fer as Chairman of the Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/33395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=33395"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/33395\/revisions"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=33395"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=33395"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=33395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}